Oncogenic osteomalacia: Clinical Trials

3 trials for Oncogenic osteomalacia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1

Follow Oncogenic osteomalacia: new trials by email Literature Review of Oncogenic osteomalacia trials Research Report on Oncogenic osteomalacia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BGJ398 for the Treatment of Tumor-Induced Osteomalacia
BGJ398 - Tumor-Induced Osteomalacia, Oncogenic Osteomalacia
Phase 2TerminatedNational Institute of Dental and Craniofacial Research (NIDCR)42019-02-272026-11-10
A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
KRN23 - Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
Phase 2CompletedKyowa Kirin Co., Ltd.142016-04-012022-09-06
Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
Burosumab - Tumor Induced Osteomalacia (TIO), Epidermal Nevus Syndrome (ENS)
Phase 2CompletedKyowa Kirin, Inc.172015-03-242024-05-06

Narrower conditions

Nevus, Sebaceous of Jadassohn (2)  ·  Hypophosphatemia (1)

Broader conditions

Abnormalities, Multiple (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Nervous System Diseases (2)  ·  Neurocutaneous Syndromes (2)  ·  Nevi and Melanomas (2)  ·  Nevus (2)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Phosphorus Metabolism Disorders (1)

Interventions

burosumab (2)  ·  infigratinib (1)

Sponsors

Kyowa Kirin Co., Ltd. (1)  ·  Kyowa Kirin, Inc. (1)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (1)

Countries

United States (2)  ·  Japan (1)  ·  South Korea (1)

Top investigators

Rachel I Gafni, M.D. (1)

Results publications

PMID 34660853